Structural antitumoral activity relationships of synthetic chalcones

International Journal of Molecular Sciences

Volumn 10, Issue 1, 2009, Pages 221-231

  Echeverria, Cesar ^a   Santibañez, Juan Francisco ^a   Donoso Tauda, Oscar ^b   Escobar, Carlos A ^b   Ramirez Tagle, Rodrigo ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Antitumoral activity; DFT; Structure activity relationships

Indexed keywords

2' HYDROXYCHALCONE; CHALCONE DERIVATIVE; UNCLASSIFIED DRUG;

ADIABATICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; SOLVENT EFFECT; STRUCTURE ACTIVITY RELATION;

ANTITUMORAL ACTIVITY; DFT; STRUCTURE-ACTIVITY RELATIONSHIPS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CHALCONES; HEP G2 CELLS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 59649100854     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10010221     Document Type: Article

References (31)

1. Kuo, S. Dietary flavonoids and cancer prevention: Evidence and potentials mechanisms Oncogenesis 1997, 8, 47-69.
2. Mark, C.; Nagarathnam, D. Cytotoxicities of some flavonoid analogues. J. Nat. Prod. 1991, 54, 1656-1660.
3. Dharn, D.N. The Chemistry of Chalcones and Related Compounds; Wiley: New York, 1981; p. 213.
4. Torigoo, T.; Arisawa, M.; Iloch, S.; Fujiu, M.; Mayuyama, H.B. Anti-mutagenic chalcones: Antagonizing the mutagenicity of benzo(a)pyrene in Salmonella typhymurium. Biophys. Res. Commun. 1983, 112, 833-842.
5. Sukumaran, K.; Kuttan, R. Screening of 11 ferns of cytotoxic and antitumor potential with special reference to Pityrogramma calomelanos. J. Ethnopharmacol. 1991, 36, 93-96.
6. Calliste, C.; Le Bail, J.; Trouilas, P.; Pouget, C.; Habrious, G.; Chulea, A.; Duroux, J.L. Chalcones: structural requirements for antioxidant, estrigenic and antiproliferative activities. J. Anticancer Res. 2001, 21, 3949-3956.
7. Won, S.; Liu, C.; Tsao, L.; Weng, J.; Ko, H.; Wang, J.; Lin, C. Synthetics chalcones as potential anti-inflammatory and cancer chemopreventive agents. Europ. J. Med. Chem. 2005, 40, 103-112.
8. De Vincenazo, R.; Ferlini, C.; Distefano, M.; Gaggini, C.; Riva, A.; Bombardelli, E.; Morazzoni, P.; Valenti, P.; Belluti, F.; Ranelletti, F.O.; Mancuso, S.; Scambia, G. In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother. Pharmacol. 2000, 46, 305-312.
9. Saydam, G.; Aydin, H.; Sahin, F.; Kucukogin, O.; Erciyas, E.; Terzioglu, E.; Buyukkececi, F.; Omay, S.; Cytotoxic and inhibitory effects os 4,4'-dihydrochalcone RVC-588 on proliferation of human leukemic HL-60 cells. Leuk. Res. 2003, 27, 57-64.
10. Sabzevari, O.; Galati, G.; Moridani, M.; Siraki, A.; Obrien, P. Molecular cytotoxic mechanisms of anticancer hydrochalcones. Chem. Biol. Interact. 2004, 145, 57-67.
11. Edwards, M.; Stemerick, D.; Sunkara, P. Chalcones: A new class of antimitotic agents. J. Med. Chem. 1990, 33, 1948-1954.
12. Tanigawa, S.; Fujii, M.; Hou, D. Stabilization of p53 is involved in Quercetin-induced Cell Cycle Arrest and apoptosis in HepG2 cells. Biosci. Biotechnol. Biochem. 2008, 72, 797-804.
13. Allen, P.; Newland, A. Electrophoresis DNA analysis for the detection of apoptosis. Mol. Biotechnol. 1998, 9, 247-251.
14. Kohler, C.; Orrenius, S. Evaluation of caspase activity in apoptotic cells. J. Immunol. Meth. 2002, 265, 97-110.
15. Fernandes, R.; McGowan, A.; Cotter, T. Mutant Ha-Ras overexpression inhibits drug and U.V. induced apoptosis. Anticancer Res. 1996, 16, 1691-1706.
16. Parr, R.; Pearsons, R. Absolute hardness: Companion parameter to absolute electronegativity. J. Am. Chem. Soc. 1983, 105, 7512-7516.
17. Parr, R.; Szentpaly, L.; Liu, S. Electrophilicity Index. J. Am. Chem. Soc. 1999, 121, 1922-1924.
18. Amsterdam Density Functional (ADF) code, release 2007. Vrije Universiteit: Amsterdam, The Netherlands.
19. Te Velde, G.; Bickelhaupt, F.M.; Van Gisberger, S.J.A.; Fonseca Guerra, C.; Baerends, E.J.; Snijders, J.G.; Ziegler, T.J. Chemistry with ADF. Comput. Chem. 2001, 22, 931-967.
20. Verluis, L.; Ziegler, T. The determination of molecular structures by density functional theory. The evaluation of analytical energy gradients by numerical integration. J. Chem. Phys, 1988, 88, 322-328.
21. Vosko, S.H.; Wilk, L.; Nusair, M.; Accurate spin-dependent electron liquid correlation energies for local spin density calculations: A critical analysis. Can. J. Phys. 1980, 58, 1200-1211.
22. Klamt, A. Conductor-like screening model for real solvents: A new approach to the quantitative calculation of salvation phenomena. J. Chem. Phys. 1995, 99, 2224-2235.
23. Klamt, A.; Jonas V.; Treatment of the outlying charge in continuum salvation models. J. Chem. Phys. 1996, 105, 9972-9981.
24. Quintana, P.; Yáñez, C.; Escobar, C.A.; Sicker, D.; Araya-Maturana, R.; Squella, J.A. Electrochemical approach to the radical anion formation from 2'-hydroxy chalcone derivatives. Electroanalysis 2006, 18, 521-525.
25. Thornberry, N.; Lazebnik, Y. Caspases: Enemies within. Science 1998, 281, 1312-1316.
26. Kobori, M.; Iwashita, K.; Shinmoto, H.; Tsushida, T. Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells. Biosci. Biotechnol. Biochem. 1999, 63, 719-725.
27. Mancini, M.; Nicholson, D.; Roy, S. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implication for apoptotic signaling. J. Cell Biol. 1998, 140, 1485-1495.
28. Perez, P.; Toro-Labbe, A.; Aizman, A.; Contreras, R. Comparison between experimental and theoretical scales of electrophilicity in benzhydryl cations. J. Org. Chem. 2002, 67, 4747-4752.
29. Li, X.; Cai, Z.I.; Sevilla, M.D. DFT Calculations of the electron affinities of nucleic acid bases: dealing with negative electron affinities. J. Phys. Chem. A 2002, 106, 1596-1603.
30. Javitt N. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990, 4, 161-168.
31. Sakahira, H.; Enari, M.; Ohsawa, Y.; Uchiyama, Y.; Nagata, S. Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol. 1999, 20, 543-546.